Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Mar 13, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-09$0.09/sh+1,000$90→ 3,131,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-13$0.09/sh+1,000$90→ 3,134,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-11$0.09/sh+2,000$180→ 3,133,073 total